This designation enables enhanced resources for law enforcement in areas significantly affected by drug trafficking, aligning with the policies of the Trump Administration and the objectives of Homeland Security Task Forces to mitigate illicit drug use and protect American lives.
Washington, D.C. – The White House Office of National Drug Control Policy (ONDCP) has announced the inclusion of two additional counties into the ONDCP-funded High Intensity Drug Trafficking Areas (HIDTA) Program. This initiative is designed to coordinate efforts among federal, state, local, tribal, and territorial agencies to disrupt and dismantle drug trafficking organizations across the United States, including Puerto Rico and the District of Columbia. The HIDTA Program bolsters the endeavors of the Homeland Security Task Force, facilitating a collaborative and conflict-free approach to counterdrug operations.
The two newly added regions are:
- St. Joseph County, Indiana (Indiana HIDTA)
- Rogers County, Oklahoma (Texoma HIDTA)
“The Trump Administration is utilizing every available authority to prevent hazardous illicit drugs from infiltrating our communities,” remarked Acting Director Victor Avila. “The HIDTA Program acts as a force-multiplier in our mission to dismantle the criminal networks responsible for saturating our neighborhoods with harmful substances like fentanyl. These new designations will equip these regions with essential resources and support to tackle the challenges posed by drug trafficking organizations.”
Since its establishment in 1988, the HIDTA Program has provided crucial assistance to public safety officials in executing coordinated operations against drug trafficking networks. Under the guidance of the ONDCP, it has emerged as a cost-effective strategy to address addiction and the overdose epidemic. In 2024 alone, HIDTAs reported seizing approximately $18 billion in illicit drugs and cash—yielding an impressive return on investment of $68.07 for each dollar allocated to the HIDTA Program.
For a visual representation of the HIDTA Program, please click HERE.
Explore the Trump Administration’s Statement of Drug Policy Priorities HERE.
